α-glucosidase x MGAM x GANC x AMYs

The main purpose of the study is to study the pharmacodynamic characteristics of the test preparation acarbose tablets (specification: 0.1g, manufacturer: Beijing Shuanglu Pharmaceutical Co., Ltd.) and the reference preparation acarbose tablets (trade name: Baytangping®, specification: 0.1g, licensee is Bayer Pharmaceuticals Co., Ltd.) when administered as a single dose to healthy subjects in the fasting state, and to evaluate the bioequivalence of the two preparations in humans. The secondary purpose of the study is to observe the safety of the test preparation acarbose tablets and the reference preparation Baytangping® in healthy subjects.

Main research purpose: This study aims to study the pharmacodynamic characteristics of acarbose tablets (specification: 50 mg) developed and produced by Shanghai Modern Pharmaceutical Co., Ltd. when taken orally under fasting conditions, and to compare the pharmacodynamic parameters of the two preparations and evaluate the bioequivalence of the two preparations in humans using acarbose tablets (Baytangping®, specification: 50 mg) certified by Bayer Healthcare Co., Ltd. as the reference preparation. Secondary research purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.